Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Apr. 30, 2019
Apr. 30, 2018
Apr. 30, 2019
Apr. 30, 2018
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 4,222,193 4,153,228 13,708,168 10,561,314
General and administrative 2,691,796 5,138,942 9,189,293 12,943,077
Loss from operations (6,913,989) (9,292,170) (22,897,461) (23,504,391)
Other income, net 113,360 91,217 333,665 148,731
Interest expense (987) (987)
Loss on disposal of property and equipment (859,600) (875,098)
Foreign currency exchange loss, net (77,965) (185,967)
Realized loss on sale of securities, net (12,134)
Warrant inducement expense (2,465,396)
Loss before income taxes (6,879,581) (10,060,553) (22,762,884) (26,696,154)
Provision for income taxes 3,520 10,860 952
Net loss $ (6,883,101) $ (10,060,553) $ (22,773,744) $ (26,697,106)
Basic and diluted net loss per common share $ (1.03) $ (1.98) $ (3.71) $ (7.46)
Weighted average shares used in computing basic and diluted net loss per common share 6,664,863 5,087,250 6,146,676 3,580,669